4D Molecular Therapeutics, Inc.

Q4 2023 13F Holders

Symbol
FDMT
CUSIP
35104E100
Type
Equity
Class
COM
Num filings
121
Total reported value, excl. options
$917 M
Manager Report Date Value ($000) Shares Option Type